Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation

Journal of Adolescent Health

Volumn 58, Issue 3, 2016, Pages 284-289

  Obijuru, Laura ^a   Bumpus, Suzanne ^a,b   Auinger, Peggy ^a   Baldwin, Constance D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Adolescents; Etonogestrel implant; Intrauterine device; Irregular bleeding; Long acting reversible contraception; Nuisance bleeding; Unintended pregnancy

Indexed keywords

DOXYCYCLINE; ETONOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT; DESOGESTREL;

ADOLESCENT; ALOPECIA; AMENORRHEA; ARTICLE; BLEEDING; BODY MASS; BREAST DISEASE; CLINICAL ASSESSMENT; CONDOM; DEVICE REMOVAL; DRUG SAFETY; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; IMPLANTATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICATION THERAPY MANAGEMENT; METRORRHAGIA; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RISK FACTOR; SUBDERMAL IMPLANT; VAGINA BLEEDING; ADOLESCENT PREGNANCY; PREGNANCY; PREVENTION AND CONTROL; RETROSPECTIVE STUDY; UTERINE HEMORRHAGE; YOUNG ADULT;

ADOLESCENT; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; FEMALE; HUMANS; PATIENT SATISFACTION; PREGNANCY; PREGNANCY IN ADOLESCENCE; RETROSPECTIVE STUDIES; UTERINE HEMORRHAGE; YOUNG ADULT;

EID: 84958978902     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2015.10.254     Document Type: Article

References (18)

1. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: Preliminary data for 2008. National Vital Statistics Reports vol. 58 no 16 2010 National Center for Health Statistics Hyattsville, Maryland
2. L. Finer, and S. Henshaw Disparities in rates of unintended pregnancy in the United States. 1994 and 2001 Perspect Sex Reprod Health 38 2006 90
3. L. Finer, and M. Zolna Unintended pregnancy in the United States: Incidence and disparities, 2006 Contraception 84 2011 478 485
4. J.C. Abma, G.M. Martinez, and C.E. Copen Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, National Survey of Family Growth 2006-2008 Vital Health Stat 23 2010 1 47
5. J.J. Frost, and J.E. Darroch Factors associated with contraceptive choice and inconsistent method use, United States, 2004 Perspect Sex Reprod Health 40 2008 94 104
6. Committee ACOG. Opinion No. 539, October 2012. Adolescents and long-acting reversible contraception: Implants and intrauterine devices.
7. American Academy of Pediatrics Committee on Adolescents Pediatrics 134 2014 e1244 e1256
8. L.B. Finer, J. Jerman, and M.L. Kavanaugh Changes in use on long-acting contraceptive methods in the United States, 2007-2009 Fertil Steril 98 2012 893 897
9. J.R. Rosenstock, J.F. Peipert, T. Madden, and et al. Continuation of reversible contraception in teenagers and young women Obstet Gynecol 120 2012 1298 1305
10. J.F. Peipert, Q. Zhao, J.E. Allsworth, and et al. Continuation and satisfaction of reversible contraception Obstet Gynecol 117 2011 1105 1113
11. S. Funk, M.M. Miller, D.R. Mishell Jr., and et al. Safety and efficacy of ImplanonTM, a single-rod implantable contraceptive containing etonogestrel Contraception 71 2005 319 326
12. P.M. Casey, M.E. Long, M.L. Marnach, and et al. Association of body mass index with removal of etonogestrel subdermal implant Contraception 87 2013 370 374
13. D. Mansour, T. Korver, M. Marintcheva-Petrova, and I.S. Fraser The effects of Implanon on menstrual bleeding patterns Eur J Contracept Reprod Health Care 13 Suppl 1 2008 13 28
14. O. Graesslin, and T. Korver The contraceptive efficacy of implanon: A review of clinical trials and marketing experience Eur J Contracept Reprod Health Care 13 Suppl 1 2008 4 12
15. M. O'neil-Callahan, J.F. Peipert, Q. Zhao, and et al. Twenty-four month continuation of reversible contraception Obstet Gynecol 122 2013 1083 1091
16. D. Mansour, L. Bahamondes, H. Critchley, and et al. The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users Contraception 83 2011 202 210
17. W. Modesto, M.V. Bahamondes, and L. Bahamondes A randomized clinical trial of the effect of intensive versus non-intensive counseling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives Hum Reprod 29 2014 1393 1399
18. P.M. Casey, M.E. Long, L.B. Drozdowicz, and et al. Management of etonogestrel subdermal implant-related bleeding J Reprod Med 59 2014 306 312